Retraction Watch

Tracking retractions as a window into the scientific process

Archive for the ‘china retractions’ Category

Retraction, tell-all style, for breast cancer radiology paper

with 5 comments

acta radHere at Retraction Watch, we don’t believe in the expression “TMI.” But this case features a level of detail we’re not sure we’ve seen before.

Acta Radiologica has pulled a 2012 article on breast cancer imaging for being a duplicate publication — a sin the retraction notice takes great pains to point out.

The notice, written by journal editor Arnulf Skjennald, has the blow-by-blow feel of a police report: Read the rest of this entry »

Written by amarcus41

September 24th, 2014 at 9:30 am

Economics paper retracted for plagiarism after citing its twin

with 2 comments

econmodAs we’ve pointed out before, economics and business journals have few retractions compared with the other academic literature. Opinions vary on why this is, but the fact that only a few journals have plagiarism policies can’t help.

Research Papers in Economics, or RePEc, an organization that maintains a database of economics papers, however, thoroughly investigates accusations of misconduct. A RePEc report, which indicated that the plagiarists were polite enough to cite the original paper, was used in the notice as evidence for a retraction in Economic Modelling.

Here’s the notice for “Retraction notice to “Analysis of nonlinear duopoly game with heterogeneous players”: Read the rest of this entry »

Written by Cat Ferguson

September 19th, 2014 at 9:30 am

Fudged figures sink breast cancer paper

with 22 comments

oncogeneA prestigious cancer journal has pulled an article over “concerns” regarding some of the figures, which PubPeer commenters had tagged as suspect.

A few weeks after the paper was published on June 9, comments on PubPeer began accumulating. Commenters called out both potentially manipulated and repeated images. The exact timeline is not clear, because Oncogene does not list a date on the retraction notice, but by August 29 the paper had been retracted.

Here’s the notice for “IL-6 secreted by cancer-associated fibroblasts induces tamoxifen resistance in luminal breast cancer,” by researchers at Shanghai Jiaotong University School of Medicine and Ruijin Hospital, both in Shanghai, China, and the University of Michigan: Read the rest of this entry »

Tonic-clonic stats error sinks epilepsy paper

with one comment

pm_cover_dez_01A brain imaging study in children with epilepsy has been retracted by the Journal of Magnetic Resonance Imaging due to a statistics error.

Here’s the notice for “Microstructural Brain Abnormalities of Children of Idiopathic Generalized Epilepsy With Generalized Tonic-Clonic Seizure: A Voxel-Based Diffusional Kurtosis Imaging Study”: Read the rest of this entry »

Wasted breath: Cribbing earns retraction of anesthesia paper

with one comment

cbandbThe authors of a paper on anesthetic waste gases in the operating room have pulled the article for plagiarism.

The paper, titled “Further Pieces of Evidence to the Pulmonary Origin of Sevoflurane Escaping to the Operating Room During General Anaesthesia,” appeared in Cell Biochemistry and Biophysics and came from a group at various institutions in Harbin, China.

But according to the retraction notice, the further pieces weren’t really further, after all:
Read the rest of this entry »

Sampling the wrong part of the aorta sinks aneurysm paper

with one comment

plosoneA paper on an experimental treatment for abdominal aneurysms has been retracted after it was discovered samples had been taken from the wrong part of the aorta.

Here is the PLOS ONE notice for “Inhibition of Rho-Kinase by Fasudil Suppresses Formation and Progression of Experimental Abdominal Aortic Aneurysms:” Read the rest of this entry »

Written by Cat Ferguson

August 21st, 2014 at 9:30 am

I know you are but what am I? School program paper pulled for duplication

without comments

sciworldjrnlAn article on youth development programs in Hong Kong has been retracted for its similarity to another article on youth development programs by the same authors.

The paper, “Process Evaluation of a Positive Youth Development Program in Hong Kong Based on Different Cohorts,” appeared in 2012 in The Scientific World Journal, and was written by a pair of researchers with appointments in Hong Kong, Macau, Shanghai, and the United States. It has been cited twice, according to Thomson Scientific’s Web of Knowledge.

According to the abstract: Read the rest of this entry »

Serial figure fakers have expression of concern upgraded to a retraction

with 7 comments

Another retraction has appeared up for frequent fliers Jun Li, Kailun Zhang and Jiahong Xia at Huazhong Science and Technology University in Wuhan, China.

We’ve covered them twice before, for a variety of retractions, corrections, and expressions of concern.

The retraction, in Clinical and Experimental Immunology, upgrades an expression of concern published earlier this year, and is the team’s fourth.

Here’s the notice for “CCR5 blockade in combination with rapamycin prolongs cardiac allograft survival in mice”: Read the rest of this entry »

“Authors, please call us. Pretty please? OK, we’re going to retract your paper!”

with 8 comments

dovelogoThe title of this post isn’t exactly how the one-sided conversation between the editors of Neuropsychiatric Disease and Treatment and a group of researchers went. But it seems likely it was pretty close.

Here’s an expression of concern for “A cross-sectional study on perception of stigma by Chinese schizophrenia patients:” Read the rest of this entry »

Written by Ivan Oransky

July 29th, 2014 at 12:45 pm

“Lack of experience and understanding” forces duplication retractions of liver cancer paper

with one comment

dovelogoA group of researchers in China has lost their paper on liver cancer after the first author admitted to duplication, also known, inelegantly, as self-plagiarism.

The paper, “Glycyrrhetinic acid-modified chitosan nanoparticles enhanced the effect of 5-fluorouracil in murine liver cancer model via regulatory T-cells,” appeared in the July 2013 issue of the Journal of Drug Design, Development and Therapy, a Dove Press title.

According to the abstract: Read the rest of this entry »